Open AccessReducing of Defects in the Drug Tablets Production Process with DMAIC to Improve Quality – Study Case of Pharmaceutical Industry
Author(s) -
Adha Winatie,
Dana Santoso Saroso,
Humiras Hardi Purba,
Ayu Puspa Wirani
Publication year - 2020
Publication title -
iop conference series. materials science and engineering
Language(s) - English
Resource type - Journals
eISSN - 1757-899X
pISSN - 1757-8981
DOI - 10.1088/1757-899x/852/1/012126
Subject(s) - dmaic , six sigma , pareto chart , ishikawa diagram , computer science , quality (philosophy) , manufacturing engineering , process (computing) , product (mathematics) , reliability engineering , operations management , pareto principle , engineering , root cause , mathematics , geometry , operating system , philosophy , epistemology , lean manufacturing
The high defect and unstable of defects the company in 2017 amounted to 0.27% while the amount allowed by this company was 0.10%. In This research was carried out in a Pharmaceutical Industry with the purpose of reducing the product spots drug tablets, the research method uses the DMAIC stages Define, Measure, Analyze, Improve and Control. The tools used are SIPOC diagrams, pareto diagrams, P charts, minitabs to calculate sigma levels and improvment with FMEA. The number of reject spots for tablets in 2018 was 0.28% and the sigma level was 4.63, then after analysis and DMAIC the reject rate was reduced to 0.0081% and sigma level 5.45.